Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2018
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of Cancers
01-05-18
Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
27-04-18
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
02-02-18
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
31-01-18
Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings
29-01-18
Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals
18-01-18
Crown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems Integration
16-01-18
Cannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.
10-01-18
Cannabis Science Actively Pursuing U.S. Federal Government Contracts and Is Preparing Applications for Submission While Confirming the CBIS Security Team (CBISST) is Ready for Action
09-01-18
Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government Contracts, Supported US Federal Governments Since 2009, Looks for New Federal Policy to Properly Regulate Industry for Patients
05-01-18
Start
Prev
1
2
3
4
5
6
Next
End